COLD CURE IS COMING: WHY ROSIN COULD BE NEW YORK’S NEXT BIG CANNABIS OPPORTUNITY

There’s a shift happening in New York’s cannabis culture, and I believe we are still in the very early stages of it.

Cold-cure rosin is beginning to get the attention it deserves.

For those who have been around cannabis for a while, concentrates are nothing new. But there is a major difference between simply selling concentrates and creating a premium solventless experience that makes consumers want to come back for more. That is where cold-cure rosin enters the picture.

And if you ask OG Strain, the New York market is about to get very interesting.

FROM FLOWER TO THE DAB RIG

For decades, flower has been the foundation of cannabis culture. You bought an eighth, broke it up, rolled it, packed a bowl, or loaded it into a vaporizer. Flower isn’t going anywhere overnight.

But cannabis consumers are becoming more educated.

Today’s consumer is paying attention to extraction methods, terpene profiles, texture, flavor, potency, freshness and the overall quality of the experience. People who once considered concentrates something reserved for experienced smokers are now walking into dispensaries and asking questions about rosin.

That change matters.

New York’s legal cannabis market is still relatively young, and concentrates remain a small portion of total legal sales compared with flower, vapes and other major categories. But that also means there is enormous room for growth.

The New York Office of Cannabis Management has already identified a shift toward non-flower product categories, including concentrates, vaporizers and edibles, as an important part of the evolving market.

To me, that doesn’t look like a market that has peaked.

It looks like a market that is just getting started.

WHY COLD-CURE ROSIN?

Cold-cure rosin is a type of solventless concentrate made from cannabis and processed without hydrocarbon solvents. After extraction, the rosin is cured under controlled conditions, producing the creamy, scoopable texture that many consumers have come to associate with premium cold cure.

The appeal is easy to understand.

Flavor.

Aroma.

Texture.

Terpenes.

And the craftsmanship involved in producing a quality product.

Cold-cured rosin has increasingly been positioned as a premium concentrate because consumers appreciate its rich flavor, smooth texture and solventless production. Industry coverage has also pointed to growing consumer interest in rosin despite its higher price point.

That premium is important.

Because in an industry where everybody eventually starts competing on price, quality gives a business another way to compete.

THE E-RIG EFFECT

There is another piece of this puzzle that I think is going to become increasingly important: the rise of the modern electronic dab rig.

Consumers are spending serious money on their equipment.

A new generation of e-rigs has made concentrates dramatically easier and more approachable for people who might have been intimidated by traditional torches, glass rigs and complicated setups.

Instead of heating a nail with a torch and trying to figure out the perfect temperature, today’s consumer can press a button, select a temperature and experience concentrates in a much more controlled way.

And once someone spends $150, $300, $400 or even $500 on a premium e-rig, they’re going to want something worthy of putting into it.

That’s where I believe cold-cure rosin has a tremendous opportunity.

The equipment is getting better.

The consumers are getting more educated.

The interest in solventless products is growing.

And the market is still developing.

Put those things together and you’ve got the recipe for a category that could explode.

THE SUPPLY PROBLEM

Here’s where things get really interesting for New York producers and retailers.

If you’ve been around the cannabis community and have access to quality cold-cure rosin, you’ve probably noticed something:

Good rosin doesn’t tend to sit around very long.

I’m hearing more and more about consumers actively searching for quality solventless products, while selection can still be limited depending on where they shop.

That creates an opportunity.

The New York market has expanded rapidly, but concentrates are still a relatively small share of the legal market. Meanwhile, the state continues to add retailers and develop its legal supply chain.

This is exactly the kind of environment where an early mover can establish a reputation.

Imagine being the company that becomes known for having the best selection of cold-cure rosin in your region.

Not one strain.

Not two.

A real menu.

Different cultivars. Different terpene profiles. Different price points. Different experiences.

That is how you build a following.

THE FIRST ONES TO GET IT RIGHT COULD WIN BIG

I don’t believe the future belongs simply to whoever makes the cheapest concentrate.

I believe there is going to be tremendous opportunity for the producer who can consistently deliver quality, consistency, variety and value.

Because once consumers discover a product they love, they become repeat customers.

And when that product is something they can’t easily find everywhere else?

Now you’ve created demand.

New York’s legal cannabis market is already showing signs of rapid expansion. OCM reported that legal sales were approaching $1.5 billion by April 2025, while the number of operational adult-use dispensaries had climbed substantially.

At the same time, industry data shows rosin growing nationally, with one 2025 industry analysis reporting an 8% year-over-year increase in rosin sales and an 11% increase in the number of rosin products.

That’s not proof that every New York consumer is ready to abandon flower tomorrow.

But it is a very good reason to pay attention.

THIS ISN’T ABOUT KILLING FLOWER

Let me be clear: I don’t think flower is disappearing.

Flower will always be cannabis culture.

What I do think is happening is that the cannabis consumer is becoming more sophisticated.

Someone can love flower on Monday, enjoy a pre-roll on Tuesday, take an edible on Wednesday and dab some cold-cure rosin on Thursday.

Cannabis isn’t an either-or market.

It’s becoming a more-options market.

And the businesses that recognize where consumer curiosity is heading before the rest of the market catches up are the businesses that have the opportunity to establish themselves.

NEW YORK, PAY ATTENTION

New York is still writing the next chapter of its legal cannabis story.

There are hundreds of legal dispensaries now, hundreds of brands and thousands of strains and products competing for consumer attention. OCM’s market reporting has specifically highlighted product diversification and changing consumer preferences as the market matures.

That means simply having cannabis isn’t enough anymore.

You need something people want.

You need something people remember.

And most importantly, you need something they come back looking for.

I believe cold-cure rosin has the potential to become one of those products.

The consumer education is happening.

The technology is improving.

The demand for premium solventless products is growing.

And compared with mature categories like flower, the legal concentrate category in New York still has plenty of room to develop.

So here’s my message to the plugs, processors, cultivators and entrepreneurs watching this market:

Don’t wait until everybody is asking for cold cure before you start thinking about cold cure.

Because by then, the people who recognized the opportunity early may already have built the brands, relationships and customer loyalty you’re trying to establish.

I’m looking toward 2026 and 2027, and I see a serious opportunity in premium solventless.

If you can produce exceptional rosin, maintain consistency, offer variety and actually keep it on the shelves, you may have something special.

Because when consumers finally catch up with a trend that the early adopters already understand, the demand can move very quickly.

And right now?

I think New York is standing at the beginning of that curve.

Cold cure isn’t the future of cannabis.

But it very well may be one of the biggest opportunities in New York’s cannabis future.

And OG Strain is telling you now:

Keep your eye on the cold cure.

Because I don’t think this wave has even started breaking yet.